INmune Bio, Inc.INMBNASDAQ
LOADING
|||
Cash Flow Under Pressure
Trending lower, below historical average, strong compound growth.
Left:
||||
Operating cash flow minus capital expenditures
Latest
$-33.36M
↓ 158% below average
Average (9y)
$-12.91M
Historical baseline
Range
High:$-18118.00
Low:$-43.50M
CAGR
+130.6%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $-33.36M | -178.5% |
| 2023 | $-11.98M | +47.2% |
| 2022 | $-22.69M | +47.9% |
| 2021 | $-43.50M | -386.4% |
| 2020 | $-8.94M | -66.1% |
| 2019 | $-5.38M | -161.5% |
| 2018 | $-2.06M | -138.9% |
| 2017 | $-861834.00 | -171.5% |
| 2016 | $-317379.00 | -1651.7% |
| 2015 | $-18118.00 | - |